UPDATE: JPMorgan Upgrades Esperion Therapeutics (ESPR) to Neutral Citing 'Achievable Estimates as Outcomes Data Nears'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/10/2026

1. SPY
2. NET
3. USO
4. SAIL
5. SJM
6. ETR
7. AMZN
8. MU
9. DVN
10. CBRL

Go back to UPDATE: JPMorgan Upgrades Esperion Therapeutics (ESPR) to Neutral Citing 'Achievable Estimates as Outcomes Data Nears'

Form 10-Q Esperion Therapeutics, For: Mar 31

May 3, 2022 8:58 AM EDT

... More

Form 8-K Esperion Therapeutics, For: May 03

May 3, 2022 7:20 AM EDT

Exhibit 99.1Esperion Reports First Quarter 2022 Financial Results and Provides Company Update
– Unprecedented CLEAR Outcomes Study Approaching 95% MACE... More